Electroencephalographic lateralization, clinical correlates and pharmacological response in untreated Parkinson's disease

Parkinsonism and Related Disorders

Volumn 21, Issue 8, 2015, Pages 948-953

  Mostile, Giovanni ^a   Nicoletti, Alessandra ^a   Dibilio, Valeria ^a   Luca, Antonina ^a   Pappalardo, Irene ^a   Giuliano, Loretta ^a   Cicero, Calogero Edoardo ^a   Sciacca, Giorgia ^a   Raciti, Loredana ^a   Contrafatto, Donatella ^a   Bruno, Elisa ^a   Sofia, Vito ^a   Zappia, Mario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

L dopa acute challenge test; Oscillatory networks; Parkinson's disease; Quantitative EEG index of lateralization; Short duration response

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT; CARBIDOPA; CARBIDOPA, LEVODOPA DRUG COMBINATION; DRUG COMBINATION;

ADULT; AGED; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; FEMALE; FRONTAL CORTEX; HEMISPHERIC DOMINANCE; HUMAN; MALE; OCCIPITAL CORTEX; OSCILLATORY POTENTIAL; PARKINSON DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGNAL PROCESSING; SPECTROMETRY; TASK PERFORMANCE; TEMPORAL CORTEX; THETA RHYTHM; DRUG COMBINATION; FRONTAL LOBE; MIDDLE AGED; OCCIPITAL LOBE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

AGED; ALPHA RHYTHM; ANTIPARKINSON AGENTS; BETA RHYTHM; CARBIDOPA; DRUG COMBINATIONS; ELECTROENCEPHALOGRAPHY; FEMALE; FRONTAL LOBE; FUNCTIONAL LATERALITY; HUMANS; LEVODOPA; MALE; MIDDLE AGED; OCCIPITAL LOBE; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 84937513136     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.06.006     Document Type: Article

References (30)

1. Litvak V., Jha A., Eusebio A., Oostenveld R., Foltynie T., Limousin P., et al. Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease. Brain 2011, 134:359-374.
2. Jenkinson N., Brown P. New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci. 2011, 34:611-618.
3. Oswal A., Litvak V., Sauleau P., Brown P. Beta reactivity, prospective facilitation of executive processing, and its dependence on dopaminergic therapy in Parkinson's disease. J.Neurosci. 2012, 32:9909-9916.
4. Zhang Y., Chen Y., Bressler S.L., Ding M. Response preparation and inhibition: the role of the cortical sensorimotor beta rhythm. Neuroscience 2008, 156:238-246.
5. Yaar I. EEG power spectral changes secondary to L-DOPA treatment in parkinsonian patients: a pilot study. Electroencephalogr. Clin. Neurophysiol. 1977, 43:111-118.
6. Yaar I., Shapiro M.B. Aquantitative study of the electroencephalographic response to levodopa treatment in parkinsonian patients. Clin. Electroencephalogr. 1983, 14:82-85.
7. Melgari J.M., Curcio G., Mastrolilli F., Salomone G., Trotta L., Tombini M., et al. Alpha and beta EEG power reflects L-dopa acute administration in parkinsonian patients. Front. Aging Neurosci. 2014, 6:302.
8. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999, 56:33-39.
9. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
10. Fahn S., Elton R.L., The Members of the UPDRS Development Committee Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease 1987, vol. 2:153-163. Macmillan Healthcare Information, Florham Park, NJ.
11. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
12. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000, 55:1621-1626.
13. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
14. Debener S., Beauducel A., Nessler D., Brocke B., Heilemann H., Kayser J. Is resting anterior EEG alpha asymmetry a trait marker for depression? Findings for healthy adults and clinically depressed patients. Neuropsychobiology 2000, 41:31-37.
15. Mostile G., Fekete R., Giuffrida J.P., Yaltho T., Davidson A., Nicoletti A., et al. Amplitude fluctuations in essential tremor. Park. Relat. Disord. 2012, 18:859-863.
16. Welch P.D. The use of fast fourier transforms for the estimation of power spectra: a method based on time averaging over short modified periodograms. IEEE Trans. Audio Electroacoust 1967, 15:70-73.
17. Sutton S.K., Davidson R.J. Prefrontal brain asymmetry: a biological substrate of the behavioral approach and inhibition systems. Psychol. Sci. 1997, 8:204-210.
18. Gasser T., Bächer P., Möcks J. Transformations towards the normal distribution of broad band spectral parameters of the EEG. Electroencephalogr. Clin. Neurophysiol. 1982, 53:119-124.
19. Zappia M., Montesanti R., Colao R., Branca D., Nicoletti G., Aguglia U., et al. Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease. Mov. Disord. 1997, 12:103-106.
20. Steriade M., Dossi R.C., Nuñez A. Intracellular studies of thalamic neurons generating sleep delta waves and fast (40-hz) oscillations during arousal. Basic Mechanisms of the EEG 1993, 138-140. Birkhäuser, Boston. S. Zschocke, E.-J. Speckmann (Eds.).
21. Marsden J.F., Limousin-Dowsey P., Ashby P., Pollak, Brown P. Subthalamic nucleus, sensorimotor cortex and muscle interrelationships in Parkinson's disease. Brain 2001, 124:378-388.
22. Williams D., Tijssen M., van Bruggen G., Bosch A., Insola A., Di Lazzaro V., et al. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain 2002, 125:1558-1569.
23. Kühn A.A., Tsui A., Aziz T., Ray N., Brücke C., Kupsch A., et al. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp. Neurol. 2009, 215:380-387.
24. Little S., Pogosyan A., Kuhn A.A., Brown P. β band stability over time correlates with Parkinsonian rigidity and bradykinesia. Exp. Neurol. 2012, 236:383-388.
25. Gaynor L.M., Kühn A.A., Dileone M., Litvak V., Eusebio A., Pogosyan A., et al. Suppression of beta oscillations in the subthalamic nucleus following cortical stimulation in humans. Eur. J. Neurosci. 2008, 28:1686-1695.
26. Eusebio A., Thevathasan W., Doyle Gaynor L., Pogosyan A., Bye E., Foltynie T., et al. Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J.Neurol. Neurosurg. Psychiatry 2011, 82:569-573.
27. Bruder G.E., Sedoruk J.P., Stewart J.W., McGrath P.J., Quitkin F.M., Tenke C.E. Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings. Biol. Psychiatry 2008, 63:1171-1177.
28. Baskaran A., Milev R., McIntyre R.S. The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Neuropharmacology 2012, 63:507-513.
29. Steriade M. Impact of network activities on neuronal properties in corticothalamic systems. J.Neurophysiol. 2001, 86:1-39.
30. Zappia M., Colao R., Montesanti R., Rizzo M., Aguglia U., Gambardella A., et al. Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease. Ann. Neurol. 1997, 42:245-248.